ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. EBITDA

TERUMO CORPORATION (4543)

Market cap
¥3.22T
P/E ratio
23.6x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 2025243,117+12.12%
Mar 31, 2024216,841+15.61%
Mar 31, 2023187,570+7.28%
Mar 31, 2022174,842+14.79%
Mar 31, 2021152,318-6.54%
Mar 31, 2020162,969+8.16%
Mar 31, 2019150,672+33.17%
Mar 31, 2018113,143+2.18%
Mar 31, 2017110,731-4.03%
Mar 31, 2016115,382+17.95%
Mar 31, 201597,819

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat